Blood cancer Drug's Long-Term safety checked in small Follow-Up study
NCT ID NCT02494258
First seen Apr 04, 2026 · Last updated May 16, 2026 · Updated 4 times
Summary
This study looked at the long-term safety of an oral chemotherapy drug (azacitidine) in 5 adults with blood cancers who had already taken it in earlier studies. Researchers tracked side effects and survival over time. The goal was to see if continuing the drug was safe and beneficial for these patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 101
Gainesville, Florida, 32610-0277, United States
-
Local Institution - 102
Houston, Texas, 77030, United States
-
Local Institution - 103
Baltimore, Maryland, 21231, United States
-
Manchester Royal Infirmary
Manchester, M13 9WL, United Kingdom
Conditions
Explore the condition pages connected to this study.